A phase 1 trial of the personalised NeoVax vaccine with nivolumab in ovarian cancer found the approach feasible with acceptable safety. Here is what it means.
Disclaimer: This site accepts articles from paid contributors. While moderation exists, not every submission is reviewed daily. The owner does not promote or endorse illegal services such as casinos, CBD, gambling, or betting.
